AG˹ٷ

STOCK TITAN

[8-K] Silo Pharma, Inc. Reports Material Event

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
8-K
Rhea-AI Filing Summary

United Community Banks, Inc. (UCBI) filed a Form 4 reporting that EVP & Chief Banking Officer Richard Bradshaw made a Rule 16 “G� transaction—classified as a bona-fide gift—of 328 common shares on 31 Jul 2025 at a price of $0. After the transfer, Bradshaw directly owns 77,584 shares. No derivative securities or additional transactions were disclosed. Given the small size of the gift (�0.4 % of his holdings) and the absence of a sale for consideration, the event is routine and immaterial to UCBI’s share float or governance profile.

United Community Banks, Inc. (UCBI) ha presentato un Modulo 4 segnalando che EVP e Chief Banking Officer Richard Bradshaw ha effettuato una transazione ai sensi della Regola 16 “G�, classificata come una donazione autentica, di 328 azioni ordinarie il 31 luglio 2025 al prezzo di $0. Dopo il trasferimento, Bradshaw possiede direttamente 77.584 azioni. Non sono stati divulgati titoli derivati o altre transazioni. Considerata la piccola entità del regalo (circa lo 0,4% delle sue partecipazioni) e l’assenza di una vendita a fronte di un corrispettivo, l’evento è considerato di routine e irrilevante per il flottante azionario o il profilo di governance di UCBI.

United Community Banks, Inc. (UCBI) presentó un Formulario 4 informando que el EVP y Director de Banca Richard Bradshaw realizó una transacción bajo la Regla 16 “G�, clasificada como un regalo legítimo, de 328 acciones ordinarias el 31 de julio de 2025 a un precio de $0. Tras la transferencia, Bradshaw posee directamente 77,584 acciones. No se divulgaron valores derivados ni transacciones adicionales. Dado el pequeño tamaño del regalo (�0,4 % de sus participaciones) y la ausencia de una venta con contraprestación, el evento es rutinario e irrelevante para el flotante o el perfil de gobernanza de UCBI.

United Community Banks, Inc. (UCBI)� EVP � 최고은행책임자 Richard Bradshaw가 규칙 16 “G”에 따른 거래—진정한 증여� 분류된—를 2025� 7� 31일에 328 보통�$0� 가격으� 신고� Form 4� 제출했습니다. 이전 � Bradshaw� 직접 77,584�� 보유하고 있습니다. 파생 증권이나 추가 거래� 공개되지 않았습니�. 증여 규모가 작고(보유 지분의 � 0.4%) 대가� 받고 판매하지 않은 점을 고려� � � 사건은 일상적이� UCBI� 유통 주식 수나 거버넌스 프로필에 영향� 미치지 않습니다.

United Community Banks, Inc. (UCBI) a déposé un formulaire 4 indiquant que le EVP et Directeur bancaire Richard Bradshaw a effectué une transaction selon la règle 16 « G », classée comme un don authentique, de 328 actions ordinaires le 31 juillet 2025 au prix de 0 $. Après ce transfert, Bradshaw détient directement 77 584 actions. Aucun titre dérivé ni transaction supplémentaire n’a été divulgué. Étant donné la faible taille du don (environ 0,4 % de ses avoirs) et l’absence de vente contre rémunération, cet événement est considéré comme routinier et sans impact sur le flottant ou le profil de gouvernance de UCBI.

United Community Banks, Inc. (UCBI) reichte ein Formular 4 ein, in dem berichtet wird, dass EVP und Chief Banking Officer Richard Bradshaw eine Regel 16 „G�-Transaktion � klassifiziert als echte Schenkung � von 328 Stammaktien am 31. Juli 2025 zu einem Preis von $0 durchgeführt hat. Nach der Übertragung besitzt Bradshaw direkt 77.584 Aktien. Es wurden keine derivativen Wertpapiere oder weiteren Transaktionen offengelegt. Aufgrund der geringen Größe der Schenkung (ca. 0,4 % seines Bestands) und des Fehlens eines Verkaufs gegen Entgelt ist das Ereignis routinemäßig und unerheblich für den Streubesitz oder das Governance-Profil von UCBI.

Positive
  • None.
Negative
  • None.

Insights

TL;DR: EVP gifts 328 shares; negligible impact on float or signal.

The Form 4 shows a non-monetary transfer under code G, typically a charitable gift or family transfer. The amount is de minimis relative to Bradshaw’s remaining 77.6 k-share stake and UCBI’s 119 m outstanding shares. No derivatives were exercised or disposed, so dilution and cash-flow implications are nil. Insider gifts are generally neutral signals, as they do not reflect valuation views. Governance risk remains unchanged; Bradshaw retains substantial alignment with shareholders.

United Community Banks, Inc. (UCBI) ha presentato un Modulo 4 segnalando che EVP e Chief Banking Officer Richard Bradshaw ha effettuato una transazione ai sensi della Regola 16 “G�, classificata come una donazione autentica, di 328 azioni ordinarie il 31 luglio 2025 al prezzo di $0. Dopo il trasferimento, Bradshaw possiede direttamente 77.584 azioni. Non sono stati divulgati titoli derivati o altre transazioni. Considerata la piccola entità del regalo (circa lo 0,4% delle sue partecipazioni) e l’assenza di una vendita a fronte di un corrispettivo, l’evento è considerato di routine e irrilevante per il flottante azionario o il profilo di governance di UCBI.

United Community Banks, Inc. (UCBI) presentó un Formulario 4 informando que el EVP y Director de Banca Richard Bradshaw realizó una transacción bajo la Regla 16 “G�, clasificada como un regalo legítimo, de 328 acciones ordinarias el 31 de julio de 2025 a un precio de $0. Tras la transferencia, Bradshaw posee directamente 77,584 acciones. No se divulgaron valores derivados ni transacciones adicionales. Dado el pequeño tamaño del regalo (�0,4 % de sus participaciones) y la ausencia de una venta con contraprestación, el evento es rutinario e irrelevante para el flotante o el perfil de gobernanza de UCBI.

United Community Banks, Inc. (UCBI)� EVP � 최고은행책임자 Richard Bradshaw가 규칙 16 “G”에 따른 거래—진정한 증여� 분류된—를 2025� 7� 31일에 328 보통�$0� 가격으� 신고� Form 4� 제출했습니다. 이전 � Bradshaw� 직접 77,584�� 보유하고 있습니다. 파생 증권이나 추가 거래� 공개되지 않았습니�. 증여 규모가 작고(보유 지분의 � 0.4%) 대가� 받고 판매하지 않은 점을 고려� � � 사건은 일상적이� UCBI� 유통 주식 수나 거버넌스 프로필에 영향� 미치지 않습니다.

United Community Banks, Inc. (UCBI) a déposé un formulaire 4 indiquant que le EVP et Directeur bancaire Richard Bradshaw a effectué une transaction selon la règle 16 « G », classée comme un don authentique, de 328 actions ordinaires le 31 juillet 2025 au prix de 0 $. Après ce transfert, Bradshaw détient directement 77 584 actions. Aucun titre dérivé ni transaction supplémentaire n’a été divulgué. Étant donné la faible taille du don (environ 0,4 % de ses avoirs) et l’absence de vente contre rémunération, cet événement est considéré comme routinier et sans impact sur le flottant ou le profil de gouvernance de UCBI.

United Community Banks, Inc. (UCBI) reichte ein Formular 4 ein, in dem berichtet wird, dass EVP und Chief Banking Officer Richard Bradshaw eine Regel 16 „G�-Transaktion � klassifiziert als echte Schenkung � von 328 Stammaktien am 31. Juli 2025 zu einem Preis von $0 durchgeführt hat. Nach der Übertragung besitzt Bradshaw direkt 77.584 Aktien. Es wurden keine derivativen Wertpapiere oder weiteren Transaktionen offengelegt. Aufgrund der geringen Größe der Schenkung (ca. 0,4 % seines Bestands) und des Fehlens eines Verkaufs gegen Entgelt ist das Ereignis routinemäßig und unerheblich für den Streubesitz oder das Governance-Profil von UCBI.

false 0001514183 0001514183 2025-08-04 2025-08-04 iso4217:USD xbrli:shares iso4217:USD xbrli:shares

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

FORM 8-K

 

CURRENT REPORT

 

Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934

 

Date of Report (Date of earliest event reported): August 4, 2025

 

Silo Pharma, Inc.

(Exact name of registrant as specified in its charter)

 

Nevada   001-41512   27-3046338
(State or other jurisdiction
of incorporation)
  (Commission File Number)   (IRS Employer
Identification No.)

 

677 N. Washington Boulevard

Sarasota, FL

  34236
(Address of principal executive offices)   (Zip Code)

 

Registrant’s telephone number, including area code: (718) 400-9031

 

N/A

(Former name or former address, if changed since last report)

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

 

Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

 

Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

 

Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

 

Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

Securities registered pursuant to Rule 12(b) of the Act:

 

Title of each class   Trading Symbol(s)   Name of exchange on which registered
Common Stock, par value $0.0001 per share   SILO   The Nasdaq Stock Market LLC

 

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

 

Emerging growth company

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.

 

 

 

 

 

 

Item 8.01 Other Events.

 

On August 4, 2025, the Board of Directors (“Board”) of Silo Pharma, Inc. (the “Company”) approved the establishment of a cryptocurrency advisory board (the “Crypto Advisory Board”) which will initially consists of up to three (3) members in connection with the Company’s cryptocurrency treasury strategy. On August 4, 2025, the Board appointed Corwin Yu as the initial member of the Crypto Advisory Board.

 

In connection with this initiative, on August 4, 2025, the Company entered into an advisory agreement with Corwin Yu, pursuant to which Mr. Yu will serve on the Crypto Advisory Board. In consideration of Mr. Yu’s services, the Company has agreed to grant him options to purchase 45,000 shares of its common stock at an exercise price of $0.7757 under its Amended and Restated 2020 Omnibus Equity Incentive Plan, which options will vest in 12 equal monthly installments.

 

On August 5, 2025, the Company issued a press release announcing the launch of a cryptocurrency treasury strategy, the establishment of the Crypto Advisory Board and the appointment of Mr. Yu thereto. A copy of the press release is attached hereto as Exhibit 99.1 and is incorporated herein by reference.

 

Item 9.01. Financial Statements and Exhibits.

 

(d) Exhibits.

 

Exhibit   Description
99.1   Press Release dated August 5, 2025
104   Cover Page Interactive Data File (embedded within the Inline XBRL document).

 

1

 

 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

  SILO PHARMA, INC.
     
Date: August 5, 2025 By: /s/ Eric Weisblum
    Eric Weisblum
    Chief Executive Officer

 

2

 

FAQ

What did United Community Banks' EVP Richard Bradshaw report in the Form 4?

He reported gifting 328 shares of UCBI common stock on 07/31/2025.

How many UCBI shares does Richard Bradshaw own after the transaction?

He now holds 77,584 direct shares.

What does transaction code "G" mean in a Form 4 filing?

Code G denotes a bona-fide gift of securities with no consideration exchanged.

Were any derivative securities involved in this Form 4?

No, the filing shows no derivative securities acquired or disposed.

Is this insider transaction likely to affect UCBI's stock price?

Given the small size (328 shares) and gift nature, it is considered immaterial to market dynamics.
Silo Pharma Inc

NASDAQ:SILO

SILO Rankings

SILO Latest News

SILO Latest SEC Filings

SILO Stock Data

5.23M
6.52M
9.5%
3.17%
2.2%
Biotechnology
Pharmaceutical Preparations
United States
SARASOTA